The Birth of the CRO Industry: How Parexel Transformed Drug Development | Episode 16

‍

Episode Summary

Josef von Rickenbach is a true pioneer in the pharmaceutical industry. In 1982, he co-founded Parexel, a company that would go on to define the CRO  industry as we know it today. Over the next 36 years as CEO, he led over 40 acquisitions, scaled the company to 19,000 employees, and helped set industry standards that still shape biopharma today.But Josef’s story isn’t just about business. It’s a story of relentless execution, risk-taking, and building an entirely new industry from scratch. Convincing pharma companies to outsource clinical research - an idea that was unheard of at the time - took vision, persistence, and an ability to see patterns before others did.In this conversation, we explore:

• How he identified the unmet need that led to the birth of the CRO industry
• The hardest moments of scaling Parexel from a 2-person consultancy to a global powerhouse
• How he sees the future of clinical development, including the role of AI in drug development

About The Verisian Community Podcast

The Verisian Community Podcast brings together experts in clinical trials to exchange innovative ideas and best practices central to clinical reporting, submission and review. Aligned with Verisian's mission to accelerate the evaluation and market launch of new medical treatments, each episode features expert insights, with guests ranging from statistical programmers to medical writers, to discuss the challenges and opportunities of the latest software and technology.

You can listen to us on Apple Podcasts or Spotify.